What is the right dose? The elusive optimal biologic dose in phase I clinical trials

Alex A. Adjei

Research output: Contribution to journal › Editorial › peer-review

55 Scopus citations

Fingerprint

Dive into the research topics of 'What is the right dose? The elusive optimal biologic dose in phase I clinical trials'. Together they form a unique fingerprint.